Improving life expectancy of patients with scleroderma: results from the South Australian Scleroderma Register | Semantic Scholar
@article{Kennedy2018ImprovingLE, title={Improving life expectancy of patients with scleroderma: results from the South Australian Scleroderma Register}, author={Nicholas Kennedy and Jenny G Walker and Paul Hakendorf and Peter J Roberts-Thomson}, journal={Internal Medicine Journal}, year={2018}, volume={48}, url={https://api.semanticscholar.org/CorpusID:4230441} }
A large number of patients with scleroderma are known to have decreased life expectancy, and patients diagnosed with the disorder have a high likelihood of developing central giant cell granuloma.
6 Citations
31 References
Scleroderma
- E. Lawson
- 2020
Medicine
Definitions
It is believed it is incorrect to conclude that the mechanism of this disease is linked to stimulating autoantibodies directed against PDGFRs and that the current debate on the existence of such antibodies is correct.